Suramin: A new therapeutic concept
- 30 April 1990
- journal article
- review article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (4), 417-419
- https://doi.org/10.1016/0277-5379(90)90005-e
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Suramin for prostatic cancer: A phase I/II study in advanced extensively pretreated diseaseEuropean Journal of Cancer and Clinical Oncology, 1990
- Anionic Dyes, Heparin, and Heparinoids: The Rediscovery of Polyanionic Tumor InhibitorsJNCI Journal of the National Cancer Institute, 1989
- SURAMIN FOR TREATMENT OF ADRENOCORTICAL CARCINOMAThe Lancet, 1989
- EFFECT OF SURAMIN IN A PATIENT WITH ADRENOCORTICAL CARCINOMAThe Lancet, 1989
- Heparin‐binding growth factor isolated from human prostatic extractsThe Prostate, 1988
- Effects of Suramin on the Function and Structure of the Adrenal Cortex in the Cynomolgus MonkeyJournal of Clinical Endocrinology & Metabolism, 1987
- Lack of response to suramin in patients with AIDS and AIDS-related complexThe American Journal of Medicine, 1987
- EFFECTS OF SURAMIN ON HTLV-III/LAV INFECTION PRESENTING AS KAPOSI'S SARCOMA OR AIDS-RELATED COMPLEX: CLINICAL PHARMACOLOGY AND SUPPRESSION OF VIRUS REPLICATION IN VIVOThe Lancet, 1985
- Suramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-IIIScience, 1984
- Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor virusesCancer Letters, 1979